The firm served as lead counsel for Biotec Pharmacon, ASA, a Norwegian pharmaceutical company, in patent infringement litigation initiated by patent owner Biothera, a Minnesota corporation, in the District of Minnesota in Minneapolis. The 14 patents involved in the litigation relate to, among other things, beta glucan compositions for immunotherapy. The District Court granted summary judgment of non-infringement as to 12 of the 14 patents, and the case subsequently settled.

Biopolymer Eng'g, Inc. v. Immunocorp, No. 05-536 (D. Minn. filed Mar. 14, 2005).

Experience Center

Match our Experience to Your Needs

Experience Highlights

Products liability litigation for manufacturing company
The firm served as lead counsel in defending claims based on breach of warranty and negligence allegedly resulting in an explosion at a North more
Researched and drafted privacy statement for large-market investment banking institution
Advised large-market investment banking institution in connection with reviewing and revising privacy statement. more
Financial services for a stock transfer business agency
Represented a large New York-based national independent stock transfer agency in establishing successor borrower programs in connection with more
Patent procurement and counseling services to YKK Corporation of America
Provide patent procurement and counseling services to YKK Corporation of America, an industry leader in the development of fastening and more